Risk stratification and clinical outcomes in patients with acute pulmonary embolism

Chi Ming Huang, Yen Chung Lin, Yenn Jiang Lin, Shih Lin Chang, Li Wei Lo, Yu Feng Hu, Chern En Chiang, Kang Ling Wang, Shih Ann Chen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objectives: Pulmonary embolism is a common disease associated with a high mortality rate. The risk assessment and appropriate treatment selection of patients with acute pulmonary embolism remains a challenge. Design and methods: This single center cohort study included a total of 150 patients (96 male, age = 71. ±. 15 years) with acute pulmonary embolism confirmed by spiral-computed tomography or magnetic resonance image. The prognostic performance of the clinical characteristics and laboratory values were investigated to predict the in-hospital hemodynamically instable events and 30-day all-cause mortality. Results: The rate of in-hospital hemodynamic instability and 30-day all-cause mortality was 21% and 12%, respectively. A multivariate Cox regression analysis demonstrated that a heart rate≥ 110bpm (odd ratio 4.26 [95% CI 1.42-12.77]), chronic pulmonary disease (6.47 [1.99-21.04]), WBC≥11,000mm 3 (3.78 [1.32-10.82]), and D-dimer level≥4.0μg/mL (3.68 [1.01-13.43]) independently predicted the 30-day fatal outcome. A Kaplan-Meier survival analysis showed that the categorization based on the number of risk factors was significantly associated with the likelihood of 30-day all-cause mortality (P

Original languageEnglish
Pages (from-to)1110-1115
Number of pages6
JournalClinical Biochemistry
Volume44
Issue number13
DOIs
Publication statusPublished - Sep 2011

Fingerprint

Pulmonary Embolism
Pulmonary diseases
Mortality
Hemodynamics
Magnetic resonance
Regression analysis
Risk assessment
Tomography
Fatal Outcome
Spiral Computed Tomography
Kaplan-Meier Estimate
Survival Analysis
Patient Selection
Lung Diseases
Chronic Disease
Cohort Studies
Magnetic Resonance Spectroscopy
Heart Rate
Odds Ratio
Regression Analysis

Keywords

  • Hemodynamic instability
  • Mortality
  • Prognosis
  • Pulmonary embolism
  • Risk stratification

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Risk stratification and clinical outcomes in patients with acute pulmonary embolism. / Huang, Chi Ming; Lin, Yen Chung; Lin, Yenn Jiang; Chang, Shih Lin; Lo, Li Wei; Hu, Yu Feng; Chiang, Chern En; Wang, Kang Ling; Chen, Shih Ann.

In: Clinical Biochemistry, Vol. 44, No. 13, 09.2011, p. 1110-1115.

Research output: Contribution to journalArticle

Huang, CM, Lin, YC, Lin, YJ, Chang, SL, Lo, LW, Hu, YF, Chiang, CE, Wang, KL & Chen, SA 2011, 'Risk stratification and clinical outcomes in patients with acute pulmonary embolism', Clinical Biochemistry, vol. 44, no. 13, pp. 1110-1115. https://doi.org/10.1016/j.clinbiochem.2011.06.077
Huang, Chi Ming ; Lin, Yen Chung ; Lin, Yenn Jiang ; Chang, Shih Lin ; Lo, Li Wei ; Hu, Yu Feng ; Chiang, Chern En ; Wang, Kang Ling ; Chen, Shih Ann. / Risk stratification and clinical outcomes in patients with acute pulmonary embolism. In: Clinical Biochemistry. 2011 ; Vol. 44, No. 13. pp. 1110-1115.
@article{fe28fb00d28d4c27a5ea09694d7c2683,
title = "Risk stratification and clinical outcomes in patients with acute pulmonary embolism",
abstract = "Objectives: Pulmonary embolism is a common disease associated with a high mortality rate. The risk assessment and appropriate treatment selection of patients with acute pulmonary embolism remains a challenge. Design and methods: This single center cohort study included a total of 150 patients (96 male, age = 71. ±. 15 years) with acute pulmonary embolism confirmed by spiral-computed tomography or magnetic resonance image. The prognostic performance of the clinical characteristics and laboratory values were investigated to predict the in-hospital hemodynamically instable events and 30-day all-cause mortality. Results: The rate of in-hospital hemodynamic instability and 30-day all-cause mortality was 21{\%} and 12{\%}, respectively. A multivariate Cox regression analysis demonstrated that a heart rate≥ 110bpm (odd ratio 4.26 [95{\%} CI 1.42-12.77]), chronic pulmonary disease (6.47 [1.99-21.04]), WBC≥11,000mm 3 (3.78 [1.32-10.82]), and D-dimer level≥4.0μg/mL (3.68 [1.01-13.43]) independently predicted the 30-day fatal outcome. A Kaplan-Meier survival analysis showed that the categorization based on the number of risk factors was significantly associated with the likelihood of 30-day all-cause mortality (P",
keywords = "Hemodynamic instability, Mortality, Prognosis, Pulmonary embolism, Risk stratification",
author = "Huang, {Chi Ming} and Lin, {Yen Chung} and Lin, {Yenn Jiang} and Chang, {Shih Lin} and Lo, {Li Wei} and Hu, {Yu Feng} and Chiang, {Chern En} and Wang, {Kang Ling} and Chen, {Shih Ann}",
year = "2011",
month = "9",
doi = "10.1016/j.clinbiochem.2011.06.077",
language = "English",
volume = "44",
pages = "1110--1115",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Risk stratification and clinical outcomes in patients with acute pulmonary embolism

AU - Huang, Chi Ming

AU - Lin, Yen Chung

AU - Lin, Yenn Jiang

AU - Chang, Shih Lin

AU - Lo, Li Wei

AU - Hu, Yu Feng

AU - Chiang, Chern En

AU - Wang, Kang Ling

AU - Chen, Shih Ann

PY - 2011/9

Y1 - 2011/9

N2 - Objectives: Pulmonary embolism is a common disease associated with a high mortality rate. The risk assessment and appropriate treatment selection of patients with acute pulmonary embolism remains a challenge. Design and methods: This single center cohort study included a total of 150 patients (96 male, age = 71. ±. 15 years) with acute pulmonary embolism confirmed by spiral-computed tomography or magnetic resonance image. The prognostic performance of the clinical characteristics and laboratory values were investigated to predict the in-hospital hemodynamically instable events and 30-day all-cause mortality. Results: The rate of in-hospital hemodynamic instability and 30-day all-cause mortality was 21% and 12%, respectively. A multivariate Cox regression analysis demonstrated that a heart rate≥ 110bpm (odd ratio 4.26 [95% CI 1.42-12.77]), chronic pulmonary disease (6.47 [1.99-21.04]), WBC≥11,000mm 3 (3.78 [1.32-10.82]), and D-dimer level≥4.0μg/mL (3.68 [1.01-13.43]) independently predicted the 30-day fatal outcome. A Kaplan-Meier survival analysis showed that the categorization based on the number of risk factors was significantly associated with the likelihood of 30-day all-cause mortality (P

AB - Objectives: Pulmonary embolism is a common disease associated with a high mortality rate. The risk assessment and appropriate treatment selection of patients with acute pulmonary embolism remains a challenge. Design and methods: This single center cohort study included a total of 150 patients (96 male, age = 71. ±. 15 years) with acute pulmonary embolism confirmed by spiral-computed tomography or magnetic resonance image. The prognostic performance of the clinical characteristics and laboratory values were investigated to predict the in-hospital hemodynamically instable events and 30-day all-cause mortality. Results: The rate of in-hospital hemodynamic instability and 30-day all-cause mortality was 21% and 12%, respectively. A multivariate Cox regression analysis demonstrated that a heart rate≥ 110bpm (odd ratio 4.26 [95% CI 1.42-12.77]), chronic pulmonary disease (6.47 [1.99-21.04]), WBC≥11,000mm 3 (3.78 [1.32-10.82]), and D-dimer level≥4.0μg/mL (3.68 [1.01-13.43]) independently predicted the 30-day fatal outcome. A Kaplan-Meier survival analysis showed that the categorization based on the number of risk factors was significantly associated with the likelihood of 30-day all-cause mortality (P

KW - Hemodynamic instability

KW - Mortality

KW - Prognosis

KW - Pulmonary embolism

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=80051687088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051687088&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2011.06.077

DO - 10.1016/j.clinbiochem.2011.06.077

M3 - Article

C2 - 21723271

AN - SCOPUS:80051687088

VL - 44

SP - 1110

EP - 1115

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 13

ER -